Goodman to Exclusively Distribute Embolic Coils from Micrus Endovascular.
Micrus Endovascular received approval for the devices from the Pharmaceuticals and Medical Devices Agency (PMDA), an independent administrative agency, on March 1. The devices will be used in a coil embolization procedure for cerebral aneurysms.
In Japan, approximately 35,000 people undergo surgery for treatment of cerebral aneurysm each year. Of those surgeries, about 15% utilize coil embolization. Goodman aims to generate 2 billion yen (US $17.0 million) in sales in the first year and 5 billion yen (US $42.3 million) in the third year.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Mar 15, 2006|
|Previous Article:||Japan AE Power Systems, Lion Co-develop Eco-friendly Insulation Oil for Use in Converters.|
|Next Article:||Kobayashi Pharmaceutical Launches New Supplement.|